cgp 28392 has been researched along with bay-k-8644 in 41 studies
| Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
|---|---|---|---|---|---|
| 76 | 1 | 2 | 2,555 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (65.85) | 18.7374 |
| 1990's | 12 (29.27) | 18.2507 |
| 2000's | 1 (2.44) | 29.6817 |
| 2010's | 1 (2.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barsys, V; Garaliene, V; Krauze, A; Mačys, A; Vigante, B | 1 |
| Gainullin, R; Saxon, M | 1 |
| Kunert-Radek, J; Lyson, K; Pawlikowski, M; Stepien, H | 1 |
| Bolger, GT; Campbell, N; Crowley, M; McKay, DW; O'Neill, SK; Triggle, CR | 1 |
| Fraser, S; Kenny, BA; Kilpatrick, AT; Spedding, M | 1 |
| Frank, GB | 1 |
| Alonso, MJ; Marín, J; Rico, I; Salaices, M | 2 |
| Halushka, PV; Mais, DE; Mayeux, PR | 1 |
| Dannies, PS; Law, GJ; Pachter, JA | 1 |
| Akimoto, T; Ariyoshi, S; Fujisue, T; Ichida, S; Wada, T | 1 |
| Marinov, BS; Saxon, ME | 1 |
| Brooks, HL; Gross, GJ; Preuss, KC; Warltier, DC | 1 |
| Affolter, H; Coronado, R | 1 |
| Brill, DM; Fozzard, HA | 1 |
| Criscione, L; Meier, M; Rogg, H; Truog, A | 1 |
| Schramm, M; Towart, R | 1 |
| Jakobsen, P; Mikkelsen, EO; Nyborg, NC | 1 |
| Carpenter, CL; Greenberg, DA; Messing, RO | 1 |
| Bevan, JA; Hwa, JJ | 1 |
| Aunis, D; Gandía, L; García, AG; Ladona, MG | 1 |
| Barhanin, J; Borsotto, M; Fosset, M; Galizzi, JP; Lazdunski, M; Renaud, JF; Romey, G; Schmid, A | 1 |
| Matsumura, Y; Morimoto, S; Sasaki, Y; Shinyama, H; Uriu, T | 1 |
| Malaisse, WJ; Malaisse-Lagae, F; Sener, A | 1 |
| Asem, EK; Tsang, BK | 1 |
| Jonkman, FA; Korstanje, C; Van Kemenade, JE; Van Zwieten, PA | 1 |
| Costa, G; Mikkelsen, EO; Nyborg, NC | 1 |
| Heisler, S; MacDonald, JF; Miljkovic, Z | 1 |
| Alonso, MJ; Fernández-Alfonso, MS; Marín, J; Rico, I; Salaices, M; Sánchez-Ferrer, CF | 1 |
| Filippov, A; Kobrinsky, E; Porotikov, V; Saxon, M | 1 |
| Panzer-Knodle, S; Papaioannou, S; Yang, PC | 1 |
| Fichtner, H; Herzig, JW; Kohlhardt, M | 1 |
| Groth, H; Locher, R; Neyses, L; Stimpel, M; Vetter, W | 1 |
| Kokubun, S; Reuter, H | 1 |
| Freedman, SB; Miller, RJ | 1 |
| Lazdunski, M; Méaux, JP; Renaud, JF; Romey, G; Schmid, A | 1 |
| Hof, A; Hof, RP; Loutzenhiser, R; Rüegg, UT | 1 |
| Nakamura, KT; Pichoff, BE; Uyehara, CF | 1 |
| Caviedes, P; Caviedes, R; Jaimovich, E; Olivares, E; Salas, K | 1 |
| Kanno, M; Nakaya, H; Takeda, Y; Tohse, N | 1 |
| Brochu, M; Cadorette, C; Poterek, M; Simaan, M; St-Louis, J | 1 |
2 review(s) available for cgp 28392 and bay-k-8644
| Article | Year |
|---|---|
Slow channel calcium activators, a new group of pharmacological agents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Heart; Heart Rate; Ion Channels; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Pyridines; Stimulation, Chemical; Vascular Resistance | 1985 |
Modulation of calcium channel function by drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Electric Conductivity; Heart Rate; Homeostasis; Humans; Ion Channels; Membrane Potentials; Nifedipine; Pyridines; Receptors, Cell Surface; Structure-Activity Relationship | 1985 |
39 other study(ies) available for cgp 28392 and bay-k-8644
| Article | Year |
|---|---|
Effect of 4-aryl-2-methyl-5-nitro-1,4-dihydropyridine-3-carboxylates on the guinea pig papillary muscle and isolated human vena saphena magna that is used for coronary artery bypass grafting.
Topics: Animals; Coronary Artery Bypass; Dihydropyridines; Guinea Pigs; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Saphenous Vein | 2011 |
Two subtypes of dihydropyridine-sensitive calcium channels in rat ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium Channel Agonists; Calcium Channels; Dihydropyridines; Female; Heart; In Vitro Techniques; Magnesium; Male; Myocardial Contraction; Myocardium; Nifedipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |
Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Chloride; Cell Division; DNA; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Nimodipine; Pyridines; Spleen | 1990 |
Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Agonists; Catecholamines; Chromatography, High Pressure Liquid; Dihydropyridines; Guinea Pigs; Injections, Intraperitoneal; Male; Mice; Motor Activity; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Nifedipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship | 1990 |
Selective antagonism of calcium channel activators by fluspirilene.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Binding, Competitive; Calcium Channel Agonists; Calcium Channel Blockers; Cecum; Cerebral Cortex; Female; Fluspirilene; Guinea Pigs; In Vitro Techniques; Isradipine; Kinetics; Muscle, Smooth; Oxadiazoles; Potassium; Pyridines; Radioligand Assay; Spiro Compounds | 1990 |
Dihydropyridine calcium channel antagonists block and agonists potentiate high potassium contractures but not twitches in frog skeletal muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Muscle Contraction; Nifedipine; Nitrendipine; Potassium; Pyridines; Rana pipiens | 1990 |
Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Female; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Potassium; Pyridines; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Affinity Labels; Blood Platelets; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Fura-2; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Manganese; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Stereoisomerism | 1991 |
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Radioisotopes; Dihydropyridines; Female; In Vitro Techniques; Inositol Phosphates; Nimodipine; Perfusion; Prolactin; Pyridines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thyrotropin-Releasing Hormone | 1991 |
Effects of calcium channel agonists (BAY K 8644, CGP28392 and YC-170) on 45Ca uptake by rat uterine segments.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Female; Nifedipine; Nitrendipine; Potassium Chloride; Pyridines; Rats; Rats, Inbred Strains; Uterus | 1991 |
Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Electron Transport; Eosine Yellowish-(YS); Heme; Ion Channels; Kinetics; Myoglobin; Nifedipine; Pyridines; Structure-Activity Relationship; Whales | 1985 |
Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Electric Conductivity; Ion Channels; Kinetics; Muscles; Nifedipine; Pyridines | 1985 |
Calcium channel blocking drugs. Part I: The calcium channel.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Biological Transport, Active; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Electric Conductivity; Humans; Ion Channels; Muscle, Smooth; Muscle, Smooth, Vascular; Muscles; Nifedipine; Pyridines | 1985 |
In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Biological Transport; Calcium; Guinea Pigs; Heart Rate; In Vitro Techniques; Ion Channels; Male; Mesentery; Myocardial Contraction; Nifedipine; Nitrendipine; Pyridines; Rats; Vasoconstriction | 1985 |
A comparison of effects of BAY K 8644 and CGP 28392, dihydropyridines with Ca agonistic properties, on spontaneous mechanical activity in rat portal vein: modification of effect by ultraviolet radiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Portal Vein; Pyridines; Rats; Rats, Inbred WKY; Ultraviolet Rays | 1985 |
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium | 1986 |
Dihydropyridine calcium agonists selectively enhance resistance artery myogenic tone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Calcium; In Vitro Techniques; Ion Channels; Male; Nimodipine; Potassium; Pyridines; Rabbits; Vasoconstriction | 1986 |
Dihydropyridine modulation of the chromaffin cell secretory response.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Cats; Cell Membrane Permeability; Chromaffin Granules; Chromaffin System; Female; Male; Muscarine; Nicotine; Nitrendipine; Norepinephrine; Perfusion; Potassium; Pyridines | 1987 |
Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Affinity Labels; Animals; Bepridil; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; Chick Embryo; Cholic Acids; Diltiazem; Ion Channels; Isradipine; Kinetics; Macromolecular Substances; Molecular Weight; Muscles; Myocardial Contraction; Oxadiazoles; Pyridines; Pyrrolidines; Receptors, Nicotinic; Verapamil | 1986 |
Inhibitory effects of calcium channel agonists on renin release from rat kidney cortical slices.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Dose-Response Relationship, Drug; Imidazoles; Ion Channels; Kidney Cortex; Male; Nifedipine; Pyridines; Rats; Rats, Inbred Strains; Renin; Trifluoperazine; Verapamil | 1987 |
Stimulation of insulin release by organic calcium-agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Ion Channels; Islets of Langerhans; Kinetics; Nifedipine; Pyridines | 1986 |
Effects of calcium channel activators BAY-K8644 and CGP-28392 on steroidogenesis in granulosa cells of the domestic hen.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bucladesine; Calcium; Chickens; Colforsin; Female; Granulosa Cells; Luteinizing Hormone; Progesterone; Pyridines; Steroids | 1987 |
Bay k 8644, a calcium entry promoter, as an antidote in verapamil intoxication in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Aminopyridines; Animals; Antidotes; Atrioventricular Node; Blood Pressure; Cardiovascular Agents; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Channels; Male; Pyridines; Rabbits; Verapamil | 1987 |
Influence of endothelium on the response to calcium agonists, calcium, potassium and noradrenaline in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channel Agonists; Endothelium, Vascular; Ion Channels; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Pyridines; Rats; Rats, Inbred Strains | 1988 |
Opposing actions of the enantiomers of BAY-K-8644 on calcium currents and ACTH secretion in clonal pituitary corticotrophs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenocorticotropic Hormone; Animals; Calcium Channel Agonists; Cells, Cultured; Electrophysiology; Ion Channels; Mice; Pituitary Gland; Pyridines; Stereoisomerism | 1987 |
Effects of the Ca2+ agonists, Bay K 8644 and CGP 28392, on isolated cat cerebral and peripheral arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic Fibers; Animals; Arteries; Cats; Cerebral Arteries; Female; Male; Pyridines | 1988 |
Paradoxical reversion of the inhibitory effects of dihydropyridine enantiomers on the calcium current in frog heart by CGP 28861.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channels; Drug Interactions; Female; Heart Atria; In Vitro Techniques; Male; Membrane Potentials; Pyridines; Rana ridibunda; Receptors, Nicotinic | 1989 |
Calcium uptake studies of 1,4-dihydropyridine agonists into rabbit aortic smooth muscle cells in culture.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channels; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Muscle, Smooth, Vascular; Potassium; Pyridines; Rabbits | 1989 |
The response of single cardiac sodium channels in neonatal rats to the dihydropyridines CGP 28392 and (-)-Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Calcium Channel Agonists; Cell Membrane; Cytoplasm; Dihydropyridines; Ethanol; Heart; In Vitro Techniques; Male; Myocardium; Pyridines; Rats; Sodium Channels | 1989 |
Effects of the Ca agonists Bay K 8644 and CGP 28392 on vascular smooth muscle tone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Radioisotopes; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Pyridines; Rats; Rats, Inbred Strains | 1989 |
Human red blood cells--an ideal model system for the action of calcium agonists and antagonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Erythrocytes; Humans; Ion Channels; Nicardipine; Nifedipine; Nitrendipine; Pyridines; Stimulation, Chemical; Verapamil | 1984 |
Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Cells, Cultured; Heart; Ion Channels; Kinetics; Nifedipine; Pyridines; Rats | 1984 |
Calcium channel activation: a different type of drug action.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Cadmium; Calcium; Calcium Channel Blockers; Cell Line; Diltiazem; Gallopamil; Glioma; Hybrid Cells; Ion Channels; Kinetics; Mice; Neuroblastoma; Nifedipine; Nitrendipine; Pyridines; Rats | 1984 |
Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bepridil; Calcium; Dose-Response Relationship, Drug; Ion Channels; Myocardium; Nifedipine; Pyridines; Pyrrolidines; Rats; Rats, Inbred Strains; Time Factors; Verapamil | 1984 |
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nifedipine; Potassium Chloride; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1984 |
Effect of calcium agonists, BAY K 8644 and CGP 28392, on guinea pig airway smooth muscle function during development.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aspirin; Calcium Channel Agonists; Drug Antagonism; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle Development; Muscle, Smooth; Pyridines; Trachea | 1993 |
Calcium fluxes, ion currents and dihydropyridine receptors in a new immortal cell line from rat heart muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Channels, L-Type; Cell Differentiation; Cell Division; Cell Line; Heart; Immunohistochemistry; Male; Membrane Potentials; Muscle Proteins; Myocardium; Nitrendipine; Pyridines; Rats; Rats, Inbred F344; Time Factors; Tritium | 1993 |
Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Heart; Myocardium; Nifedipine; Patch-Clamp Techniques; Pyridines; Rabbits | 1995 |
Calcium channels contribute to the decrease in blood pressure of pregnant rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Female; Hypotension; Male; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridines; Rats; Rats, Sprague-Dawley | 2002 |